Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its Philips Patient Monitors MX750 and MX850 have received 510(k) ...
A year after they were given an emergency nod to be used during the pandemic, two of Royal Philips’ newest patient monitors now are cleared by the Food and Drug Administration. The agency recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results